Percutaneous treatment of multivessel coronary disease in the drug eluting stent era: comparison of bare-metal stents, drug-eluting stents and a mixed approach in a large multicentre registry
Elisabetta Varani1, MD; Francesco Saia2, MD, PhD; Marco Balducelli1, MD; Paolo Guastaroba3, MSc; Cinzia Marrozzini2, MD; Fabio Tarantino4, MD; Francesco Passerini5, MD; Pietro Sangiorgio6, MD; Gianfranco Percoco7, MD; Roberto Grilli3, MD; Antonio Marzocchi2, MD; Aleardo Maresta1*, MD, FESC, FACC; for the REAL Investigators
1. Unità Operativa di Cardiologia, Ospedale S. Maria delle Croci, Ravenna, Italy; 2. Istituto di Cardiologia, Università di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy; 3. Agenzia Sanitaria Regionale dell’Emilia-Romagna, Bologna, Italy; 4. Lab
Background: Restenosis and a high incidence of new revascularisations reduce the long-term efficacy of percutaneous coronary intervention (PCI) in patients with multivessel coronary artery
